Recent advances in the treatment of pediatric pulmonary artery hypertension

Pediatric Clinics of North America

Volumn 46, Issue 2, 1999, Pages 331-345

  Barst, R J ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; NITRIC OXIDE; OXYGEN; PROSTACYCLIN; THROMBOXANE SYNTHASE INHIBITOR; VASODILATOR AGENT;

ANTICOAGULATION; HEART ATRIUM SEPTUM; HEART LUNG TRANSPLANTATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PULMONARY HYPERTENSION; REVIEW; SURVIVAL RATE;

EID: 0032947131     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(05)70121-8     Document Type: Article

References (41)

1. A.M. Atz I. Adatia R.A. Jonas Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis Am J Cardiol 77 1996 316 319
2. R.J. Barst Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension Chest 98 1986 497 503
3. Barst RJ, Maislin G, Fishman AP: Vasodilator therapy in primary pulmonary hypertension in children. Circulation, in press
4. R.J. Barst L.J. Rubin W.A. Long A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296 301
5. R.J. Barst Primary pulmonary hypertension in children Rubin L.J. Rich S. Primary Pulmonary Hypertension: Lung Biology in Health and Disease 1996 Marcel Dekker New York 179 225
6. M. Beghetti W. Habre B. Friedi Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients Br Heart J 73 1995 65 68
7. Berman-Rosenzweig E, Kerstein D, Barst RJ: Chronic prostacyclin therapy for pulmonary hypertension with associated congenital heart defects. Circulation, in press
8. M. Berner M. Beghetti I. SpahrSchopfer Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease Am J Cardiol 77 1996 532 535
9. J.J. Bowyer C.M. Busst D.M. Denison Effect of long-term oxygen treatment at home in children with pulmonary vascular disease Br Heart J 55 1986 385 390
10. A. Bush C. Busst W.B. Knight Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy Am Rev Respir Dis 136 1987 767 769
11. R.N. Channick J.W. Newhart F.W. Johnson Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: An ambulatory delivery system and initial clinical tests Chest 109 1996 1545 1549
12. B.W. Christman C.D. McPherson J.H. Newman An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension N Engl J Med 327 1992 70 75
13. M.C. Clabby C.E. Canter J.H. Moller Hemodynamic data and survival in children with pulmonary hypertension J Am Coll Cardiol 30 1997 554 560
14. G. Cremona T. Higenbottam Role of prostacyclin in the treatment of primary pulmonary hypertension Am J Cardiol 75 1995 67A 71A
15. V. Fuster P.M. Steele W.D. Edwards Primary pulmonary hypertension: Natural history and the importance of thrombosis Circulation 70 1984 580 587
16. A. Giaid M. Yanagisawa D. Langleben Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N Engl J Med 328 1993 173 176
17. M.J. Hausknecht R.E. Sims M.R. Nihill Successful palliation of primary pulmonary hypertension by atrial septostomy Am J Cardiol 65 1990 449 458
18. M.J. Hausknecht R.E. Sims M.R. Nihill Successful palliation of primary pulmonary hypertension by atrial septostomy Am J Cardiol 675 1990 1045 1046
19. S.G. Haworth Pulmonary hypertension in childhood Eur Respir J 6 1993 1037 1043
20. D. Heath J.E. Edwards The pathology of hypertensive pulmonary vascular disease: A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects Circulation 18 1958 533 547
21. R.A. Hopkins C. Bull S.G. Haworth Pulmonary hypertensive crises following surgery for congenital heart defects in young children Eur J Cardiothorac Surg 5 1991 628 634
22. D. Kerstein P.S. Levy D.T. Hsu Blade balloon atrial septostomy improves survival in patients with severe primary pulmonary hypertension Circulation 91 1995 2028 2035
23. L. Kidd D.J. Driscoll W.M. Gersony Second natural history study of congenital heart defects: Results of treatment of patients with ventricular septal defects Circulation 87 1993 38 51
24. V.V. McLaughlin D.E. Genthner M.M. Panella Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension N Engl J Med 338 1998 273 277
25. O.I. Miller D.S. Celemajer J.E. Deanfield Very-low-dose inhaled nitric oxide: A selective pulmonary vasodilator after operations for congenital heart disease J Thorac Cardiovasc Surg 108 1994 487 494
26. M.K. Pasque E.P. Trulock J.D. Cooper Single lung transplantation for pulmonary hypertension: Single institution experience in 34 patients Circulation 92 1995 2252 2258
27. J. Pepke-Zaba T. Higenbottam A.T. Dinh-Xuan Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension Lancet 338 1991 1173 1174
28. M. Rabinovitch S.G. Haworth A.R. Castaneda Lung biopsy in congenital heart disease: A morphometric approach to pulmonary vascular disease Circulation 58 1978 1107 1122
29. S. Rich D.R. Dantzker S.M. Ayres Primary pulmonary hypertension: A national prospective study Ann Intern Med 107 1987 216 223
30. S. Rich E. Kaufmann P.S. Levy The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 1992 76 81
31. Roberts J.D. Jr P. Lan L.M. Bigatello Inhaled nitric oxide in congenital heart disease Circulation 87 1993 447 453
32. A. Rozkovec P. Montanes C. Oakley Factors that influence the outcome of primary pulmonary hypertension Br Heart J 55 1986 449 458
33. L.J. Rubin Primary pulmonary hypertension Chest 104 1993 236 250
34. O. Sitbon F. Brenot A. Denjean Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension Am J Respir Crit Care Med 151 1995 384 389
35. D.J. Stewart R.D. Levy P. Cernacek Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease? Ann Intern Med 114 1991 467 469
36. S.C. Sweet T.L. Spray C.B. Huddleston Pediatric lung transplantation at St. Louis Children's Hospital, 1990–1995 Am J Resp Crit Care Med 155 1997 1027 1035
37. C.A. Wagenvoort N. Wagenvoort Pathology of Pulmonary Hypertension 1977 Wiley & Sons New York
38. C.A. Wagenvoort N. Wagenvoort Primary pulmonary hypertension: A pathologic study of the lung vessels in 156 clinically diagnosed cases Circulation 42 1970 1163 1184
39. D.L. Wessel I. Adatia T.M. Giglia Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass Circulation 99 1993 2128 2138
40. P. Wood The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt BMJ 2 1958 701 709
41. S. Yamaki H. Mohri K. Haneda Indications for surgery based on lung biopsy in cases of ventricular septal defects and/or patent ductus with severe pulmonary hypertension Chest 96 1989 31 39